The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 5 , Pages 1143-1152, November 2010

Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on ischemic myocardium

Read at the 90th Annual Meeting of The American Association for Thoracic Surgery, Toronto, Ontario, Canada, May 1–5, 2010.

  • Michael P. Robich, MD, MSPH

      Affiliations

    • Department of Surgery, Division of Cardiothoracic Surgery, Warren Alpert School of Medicine, Brown University, Providence, RI
    • Department of Surgery, Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass
    • ,
  • Louis M. Chu, MD

      Affiliations

    • Department of Surgery, Division of Cardiothoracic Surgery, Warren Alpert School of Medicine, Brown University, Providence, RI
    • ,
  • Jun Feng, MD, PhD

      Affiliations

    • Department of Surgery, Division of Cardiothoracic Surgery, Rhode Island Hospital, Providence, RI
    • ,
  • Thomas A. Burgess, MA

      Affiliations

    • Department of Surgery, Division of Cardiothoracic Surgery, Rhode Island Hospital, Providence, RI
    • ,
  • Roger J. Laham, MD

      Affiliations

    • Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass
    • ,
  • Cesario Bianchi, MD, PhD

      Affiliations

    • Department of Surgery, Division of Cardiothoracic Surgery, Rhode Island Hospital, Providence, RI
    • ,
  • Frank W. Sellke, MD

      Affiliations

    • Department of Surgery, Division of Cardiothoracic Surgery, Warren Alpert School of Medicine, Brown University, Providence, RI
    • Department of Surgery, Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass
    • Department of Surgery, Division of Cardiothoracic Surgery, Rhode Island Hospital, Providence, RI
    • Corresponding Author InformationAddress for reprints: Frank W. Sellke, MD, Division of Cardiothoracic Surgery, Cardiovascular Research Center, Alpert Medical School, Brown University, 593 Eddy St, APC 424, Providence, RI 02903.

Received 22 April 2010; received in revised form 28 May 2010; accepted 28 June 2010. published online 01 September 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the National Heart, Lung and Blood Institute (F.S.W.) grants RO1HL46716, RO1HL69024, and RO1HL85647; by the National Institutes of Health (M.P.R.) grant 5T32-HL0074; and by the Irving Bard Memorial Fellowship (M.P.R., L.M.C.).

 Disclosures: F.W.S. has research support from Ikaria (Clinton, NJ) and Orthologic (Tempe, Ariz) and is a consultant for Novo Nordisk (Princeton, NJ) and Cubist Pharmaceuticals (Lexington, Mass). F.W.S. is a consultant for the law firms representing Pfizer (Princeton, NJ) in the Bextra/Celebrex litigation, but no funding was received for this study, and there was no consultation or notification regarding this study.

PII: S0022-5223(10)00765-8

doi:10.1016/j.jtcvs.2010.06.057

The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 5 , Pages 1143-1152, November 2010

Article Tools

* Image Usage & Resolution